Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06794983 · ClinicalTrials.gov registry record · NA
Calls and Coordination for Transitions of Care at Re-entry
A NA study of Substance Use Disorder (SUD) and Chronic Medical Conditions, sponsored by University of Wisconsin, Madison.
- Recruiting
- Registry status
- NA
- Development phase
- 488
- Enrollment target
- 1
- Study location
NCT06794983: Recruiting NA study of Substance Use Disorder (SUD) and Chronic Medical Conditions, sponsored by University of Wisconsin, Madison.
NCT06794983 is a NA study of Substance Use Disorder (SUD) and Chronic Medical Conditions that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 488 participants, above the 216-participant average among 15 other Substance Use Disorder (SUD) trials with a reported enrollment target (126% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06794983, a NA study of Substance Use Disorder (SUD) and Chronic Medical Conditions, is actively recruiting participants, sponsored by University of Wisconsin, Madison.
- RECRUITING
- Registry status
- NA
- Development phase
- 488 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn if a short program for people being released from prison can help connect them to medical care. The main question it aims to answer is: * Will there be more non-emergency, outpatient clinic visits? Researchers will compare the number of clinic visits between people who use a Nurse Case Manager (NCM) to people in enhanced usual care. Participants will: * Complete surveys * Talk to a study team member 2-3 times, or talk to a study team member 2-3 times and talk to an NCM 6-11 times
Conditions Studied
Interventions
- OTHER In-person visit with study team member
- OTHER In-person visit with NCM
- OTHER Phone calls and texts
- OTHER Phone calls and texts - NCM
Study Locations (1)
Wisconsin
- University of Wisconsin - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 488 participants |
| Start Date | 2025-09-19 |
| Est. Completion | 2029-04-30 |
| Phase | NA |
What NCT06794983 shows while recruiting
NCT06794983 is an interventional study that assigns participants to a tested intervention. The registered 488 participants enrollment target is mid-sized for trials with a published cap, above the 216-participant average among 15 other Substance Use Disorder (SUD) trials with a reported enrollment target (126% higher).
The record links to 5 conditions, with Substance Use Disorder (SUD) appearing as the primary indexed condition, and to 4 interventions - of which In-person visit with study team member is the first listed.
NCT06794983 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT06794983 about?
NCT06794983 is a clinical study titled "Calls and Coordination for Transitions of Care at Re-entry". The goal of this clinical trial is to learn if a short program for people being released from prison can help connect them to medical care. The main question it aims to answer is: * Will there be more non-emergency, outpatient clinic visits? Researchers will compare the number of clinic visits bet...
What is the current status of trial NCT06794983?
This trial is currently recruiting. It is a NA study. The enrollment target is 488 participants. The study started on 2025-09-19. Estimated completion is 2029-04-30.
What conditions does trial NCT06794983 study?
This clinical trial studies the following conditions: Substance Use Disorder (SUD), Chronic Medical Conditions, Prisoners, Substance Use History, Psychiatric Condition.
What interventions are being tested in trial NCT06794983?
The interventions under investigation include: In-person visit with study team member (OTHER), In-person visit with NCM (OTHER), Phone calls and texts (OTHER), Phone calls and texts - NCM (OTHER).
Who is sponsoring clinical trial NCT06794983?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06794983 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance Use Disorder (SUD)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06794983's enrollment target sits among peer trials
488 3rd of 15 higher than 13 of 15 other Substance Use Disorder (SUD) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Substance Use Disorder (SUD) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Contingency Management for Veteran Smokers Undergoing Major Elective Surgery
RECRUITING · NA
-
The Trans-Led Care Study
RECRUITING · NA
-
California MEPS Hub
RECRUITING · NA
-
Substance Use in Pregnant People - Optimizing Retention in Treatment
RECRUITING · NA
-
Individualized Adaptive Deep Brain Stimulation in Opioid Use Disorder
RECRUITING · NA
-
Adolescent Stress and Substance Intervention Subsequent to Trauma
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05154669 · 488 participants · Phase 3
Integrating Financial Coaching and Smoking Cessation Coaching
- NCT06532877 · 488 participants · NA
Telephone Support in Advanced Gastrointestinal Cancer
- NCT06602479 · 488 participants · Phase 2
A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
- NCT06948435 · 487 participants · Phase 3
A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL1
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI